19 Aug. 2025
19 Aug. 2025
Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Lab Manager to join our team at the Champalimaud Research Program.
The Cancer Dormancy & Immunity Lab, led by Dr. Ana Luisa Correia, at Champalimaud Foundation, Lisbon, Portugal, invites applications for the position of Lab Manager.
16 August 2025
An international and multidisciplinary team, led by researchers from the Champalimaud Foundation, in Lisbon, has developed an artificial intelligence algorithm that improves the reliability of prostate cancer detection based solely on magnetic resonance imaging (MRI) scans – that is, without resorting to a biopsy. Their findings were published today, 15th of August, in the journal Radiology: Imaging Cancer.
11 August 2025
“This is a historic step,” says Prof. Dr. Robert Schoevers, head of psychiatry at the University Medical Center Groningen (UMCG) and principal investigator of PsyPal. “After many months of preparation, we are thrilled to begin working directly with patients.”
This one-day event will bring together clinicians, researchers, patient representatives, policymakers and ethicists to explore the landscape of psychedelic-assisted care through the lens of the four pillars of medical ethics: beneficence, autonomy, non-maleficence, and justice.
The symposium will delve into safety, regulation, therapeutic practices, and future directions to ensure equitable access to psychedelic-assisted care.